Calpain System Regulates Muscle Mass and Glucose Transporter GLUT4 Turnover
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The experiments in this study were undertaken to determine whether inhibition of calpain activity in skeletal muscle is associated with alterations in muscle metabolism. Transgenic mice that overexpress human calpastatin, an endogenous calpain inhibitor, in skeletal muscle were produced. Compared with wild type controls, muscle calpastatin mice demonstrated normal glucose tolerance. Levels of the glucose transporter GLUT4 were increased more than 3-fold in the transgenic mice by Western blotting while mRNA levels for GLUT4 and myocyte enhancer factors, MEF 2A and MEF 2D, protein levels were decreased. We found that GLUT4 can be degraded by calpain-2, suggesting that diminished degradation is responsible for the increase in muscle GLUT4 in the calpastatin transgenic mice. Despite the increase in GLUT4, glucose transport into isolated muscles from transgenic mice was not increased in response to insulin. The expression of protein kinase B was decreased by approximately 60% in calpastatin transgenic muscle. This decrease could play a role in accounting for the insulin resistance relative to GLUT4 content of calpastatin transgenic muscle. The muscle weights of transgenic animals were substantially increased compared with controls. These results are consistent with the conclusion that calpain-mediated pathways play an important role in the regulation of GLUT4 degradation in muscle and in the regulation of muscle mass. Inhibition of calpain activity in muscle by overexpression of calpastatin is associated with an increase in GLUT4 protein without a proportional increase in insulin-stimulated glucose transport. These findings provide evidence for a physiological role for calpains in the regulation of muscle glucose metabolism and muscle mass.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As an example of posttranslational regulation, it has been shown that overexpression of calpastatin, the endogenous inhibitor of the protease calpain, results in large increases in expression of GLUT4, CAMKII, and AMPK proteins despite a decrease or no change in their mRNA levels (48, 49).”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [48]
In the citing paper
“This approach ignores the fact that genes are expressed as proteins and that gene expression can be regulated at a number of steps during translation as well as posttranslationally.”
From High-fat diets cause insulin resistance despite an increase in muscle mitochondria (2008) · cites this paper as [48]
Citations
Cites
GOLL, D. E., THOMPSON, V. F., LI, H., WEI, W., & CONG, J. (2003) · Physiological Reviews · doi:10.1152/physrev.00029.2002 · Cited by 2,829
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Self-citationFacilitative glucose transporters
MUECKLER, M. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18550.x · Cited by 1,093
A comparison of three methods of glycogen measurement in tissues
Passonneau, J. V., & Lauderdale, V. R. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90248-6 · Cited by 739
Lecker, S. H., Solomon, V., Mitch, W. E., & Goldberg, A. L. (1999) · The Journal of Nutrition · doi:10.1093/jn/129.1.227s · Cited by 732
Hanis, C. L., Boerwinkle, E., Chakraborty, R., Ellsworth, D. L., Concannon, P., Stirling, B., Morrison, V. A., Wapelhorst, B., Spielman, R. S., Gogolin-Ewens, K. J., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-161 · Cited by 590
Self-citationHanson, R. L., Ehm, M. G., Pettitt, D. J., Prochazka, M., Thompson, D. B., Timberlake, D., Foroud, T., Kobes, S., Baier, L., Burns, D. K., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/302061 · Cited by 475
Fukumoto, H., Kayano, T., Buse, J. B., Edwards, Y., Pilch, P. F., Bell, G. I., & Seino, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83106-4 · Cited by 474
Self-citationThe calpain family and human disease
Huang, Y., & Wang, K. K. W. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02049-4 · Cited by 472
A Neutral, Calcium-activated Proteinase from the Soluble Fraction of Rat Brain
Guroff, G. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51762-2 · Cited by 438
Research works printed but not linked: 3
- Henriksen, 1990, Am. J. Physiol., 259, E593
- Ojuka, 2002, Am. J. Physiol., 282, E1008
- Garcia-Roves, 2003, Am. J. Physiol., 285, E729
Cited by
Exercise, GLUT4, and skeletal muscle glucose uptake
Richter, E. A., & Hargreaves, M. (2013) · Physiological Reviews · doi:10.1152/physrev.00038.2012 · Cited by 1,407
High-fat diets cause insulin resistance despite an increase in muscle mitochondria
Hancock, C. R., Han, D.-H., Chen, M., Terada, S., Yasuda, T., Wright, D. C., & Holloszy, J. O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802057105 · Cited by 538
“As an example of posttranslational regulation, it has been shown that overexpression of calpastatin, the endogenous inhibitor of the protease calpain, results in large increases in expression of GLUT4, CAMKII, and AMPK proteins despite a decrease or no change in their mRNA levels (48, 49).”
BackgroundSelf-citationExercise-induced mitochondrial biogenesis begins before the increase in muscle PGC-1α expression.
Wright, D. C., Han, D.-H., Garcia-Roves, P. M., Geiger, P. C., Jones, T. E., & Holloszy, J. O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606116200 · Cited by 488
Self-citationNagai, Y., Yonemitsu, S., Erion, D. M., Iwasaki, T., Stark, R., Weismann, D., Dong, J., Zhang, D., Jurczak, M. J., Löffler, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.011 · Cited by 203
“Furthermore, one report suggests that GLUT4 can be degraded by calpain-2 (Otani et al., 2004).”
BackgroundCa2+-dependent proteolysis in muscle wasting
Costelli, P., Reffo, P., Penna, F., Autelli, R., Bonelli, G., & Baccino, F. M. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.03.010 · Cited by 179
Does calorie restriction induce mitochondrial biogenesis? A reevaluation
Hancock, C. R., Han, D., Higashida, K., Kim, S. H., & Holloszy, J. O. (2011) · The FASEB Journal · doi:10.1096/fj.10-170415 · Cited by 131
“RNA was extracted from triceps muscle as described previously (17).”
MethodSelf-citationLiu, J., Marchase, R. B., & Chatham, J. C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00285.2007 · Cited by 117
“colleagues (24, 25) have reported that both the glucose transporter GLUT4 and AMP-activated protein kinase (AMPK) are also targets for calpain-mediated proteolysis.”
BackgroundCalpain-10: from genome search to function
Turner, M. D., Cassell, P. G., & Hitman, G. A. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.578 · Cited by 78
“Overexpression of the calpain inhibitor calpastatin in skeletal muscle leads to an intracellular accumulation of GLUT4, but with no concomitant increase in transporter at the plasma membrane or upregulation of glucose metabolism [79].”
BackgroundCalpain-dependent regulation of the skeletal muscle atrophy following unloading
Shenkman, B. S., Belova, S. P., Lomonosova, Y. N., Kostrominova, T. Y., & Nemirovskaya, T. L. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.07.011 · Cited by 65
Branca, D. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.126 · Cited by 59
Verbrugge, S. A. J., Schönfelder, M., Becker, L., Yaghoob Nezhad, F., Hrabě de Angelis, M., & Wackerhage, H. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00553 · Cited by 56
Salazar, J. J., Michele, D. E., & Brooks, S. V. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01080.2009 · Cited by 58
Bertipaglia, I., & Carafoli, E. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_2 · Cited by 53
Covington, M. D., & Schnellmann, R. G. (2011) · Kidney International · doi:10.1038/ki.2011.356 · Cited by 53
Polonsky, K. S., & Burant, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00031-9 · Cited by 73
Self-citationCalpains and Their Multiple Roles in Diabetes Mellitus
Harris, F., Biswas, S., Singh, J., Dennison, S. R., & Phoenix, D. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.011 · Cited by 48
Overturf, K., & Gaylord, T. G. (2008) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2008.10.012 · Cited by 41
“Interestingly, calpastatin, like MyoD, has been shown to be involved in the regulation of glucose transporters and also myocyte enhancing factors (Otani et al., 2004).”
BackgroundMechanical unloading of the heart activates the calpain system
Razeghi, P., Volpini, K. C., Wang, M., Youker, K. A., Stepkowski, S. M., & Taegtmeyer, H. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.114 · Cited by 40
Liu, X., Du, Y., Trakooljul, N., Brand, B., Muráni, E., Krischek, C., Wicke, M., Schwerin, M., Wimmers, K., & Ponsuksili, S. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13132 · Cited by 45
“Its activation promotes disassembly of myofilaments from intact myofibrillar proteins and permits the degradation of these sarcomeric proteins by UPS [38]; it is also involved in the regulation of muscle mass [39].”
BackgroundLoss of calpain 10 causes mitochondrial dysfunction during chronic hyperglycemia
Smith, M. A., Covington, M. D., & Schnellmann, R. G. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.04.020 · Cited by 37
Modi, S., Yaluri, N., Kokkola, T., & Laakso, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-17840-x · Cited by 37
The calpain system and diabetes
Pandurangan, M., Wang, S., Orhirbat, C., Jieun, Y., & Cho, S. (2014) · Pathophysiology · doi:10.1016/j.pathophys.2014.01.003 · Cited by 31
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 50
Self-citationMuroya, S., Neath, K. E., Nakajima, I., Oe, M., Shibata, M., Ojima, K., & CHIKUNI, K. (2011) · Animal Science Journal · doi:10.1111/j.1740-0929.2011.00954.x · Cited by 28
Norton, L., Parr, T., BARDSLEY, R. G., Ye, H. J., & Tsintzas, K. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01639.x · Cited by 28
“Studies in transgenic mice have shown that overexpression of the specific calpain inhibitor calpastatin resulted in a threefold increase in GLUT4 protein despite a decrease in GLUT4 mRNA (Otani et al. 2004).”
BackgroundSelf-citationMolecular Biotechnology of Development and Growth in Fish Muscle
Johnston, I. A., Macqueen, D. J., & Watabe, S. (2008) · Cited by 37
Mitochondrial calpain 10 activity and expression in the kidney of multiple species
Giguere, C. J., Covington, M. D., & Schnellmann, R. G. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.133 · Cited by 26
“have linked this genetic association of CAPN10 and type 2 diabetes to functional roles for calpain 10 in the progression of the diabetic phenotype, including regulation of glucose uptake via GLUT4 vesicles [8;9] and regulation of mitochondrial metabolism and insulin secretion [10].”
BackgroundChotechuang, N., Azzout-Marniche, D., Bos, C., Chaumontet, C., Gaudichon, C., & Tomé, D. (2011) · Amino Acids · doi:10.1007/s00726-010-0765-2 · Cited by 24
“Calpain may also be required for macroautophagy in mammalian cells (Otani et al. 2004; Demarchi et al. 2006).”
BackgroundCalpain-10 Gene Polymorphism in Type 2 Diabetes Mellitus Patients in the Gaza Strip
Alzaharna, M. M., Abed, A. A., & Sharif, F. A. (2010) · Medical Principles and Practice · doi:10.1159/000320304 · Cited by 24
Protein Turnover in Skeletal Muscle: Looking at Molecular Regulation towards an Active Lifestyle
Ferreira, R. P., & Duarte, J. A. (2023) · International Journal of Sports Medicine · doi:10.1055/a-2044-8277 · Cited by 27
“GLUT4 was also shown to be a substrate of m-cal-pain, which supports the participation of calpains in the regulation of the SkM metabolism [78].”
Calpain System Regulates the Differentiation of Adult Primitive Mesenchymal ST-13 Adipocytes
Yajima, Y., Sato, M., Sorimachi, H., Inomata, M., Maki, M., & Kawashima, S. (2006) · Endocrinology · doi:10.1210/en.2005-1647 · Cited by 22
Navegantes, L. C. C., Baviera, A. M., & Kettelhut, Í. D. C. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009000100005 · Cited by 23
“Recent findings showing that calpastatin overexpression results in skeletal muscle hypertrophy (36) and protects mice against atrophy (37) provide evidence that calpastatin is also involved in the control of normal skeletal muscle protein turnover.”
BackgroundScherp, P., Putluri, N., LeBlanc, G. J., Wang, Z. Q., Zhang, X. H., Yu, Y., Ribnicky, D., Cefalu, W. T., & Kheterpal, I. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.03.024 · Cited by 23
The role of calpain in skeletal muscle
Pandurangan, M., & Wang, S. (2012) · Animal Cells and Systems · doi:10.1080/19768354.2012.724708 · Cited by 21
“Similarly, desmin, talin, and fibronectin were shown to be cleaved by calpain during membrane cytoskeleton rearrangement concomitant with myoblast fusion (Otani et al. 2004).”
BackgroundUtrophin is a calpain substrate in muscle cells
Courdier-Fruh, I., & Briguet, A. (2006) · Muscle & Nerve · doi:10.1002/mus.20549 · Cited by 21
Baliova, M., & Jurský, F. (2005) · Neurochemical Research · doi:10.1007/s11064-005-7520-1 · Cited by 20
“Such role has been already proposed for calpain in case of the NMDA receptor (51) and the glucose transporter GLUT4 (52).”
BackgroundCalpain-10 (NIDDM1) as a Susceptibility Gene for Common Type 2 Diabetes
Horikawa, Y. (2006) · Endocrine Journal · doi:10.1507/endocrj.kr-70 · Cited by 18
Self-citationDouillard, A., Galbès, O., Begue, G., Rossano, B., Levin, J., Vernus, B., Bonnieu, A., Candau, R. B., & Py, G. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05677.x · Cited by 16
“Thus, in the transgenic mouse model overexpressing calpastatin,(11) which has increased basal levels of p-AMPK, one would expect a decreased muscle mass, but this was not confirmed in previous studies.(10,11)”
BackgroundResultInfluentialOtani, K., Polonsky, K. S., Holloszy, J. O., & Han, D.-H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00510.2005 · Cited by 14
“This large increase in GLUT4 protein occurs despite a decrease in GLUT4 mRNA (11).”
BackgroundMethodResultSelf-citationUstianowski, P., Malinowski, D., Kopytko, P., Czerewaty, M., Tarnowski, M., Dziedziejko, V., Safranow, K., & Pawlik, A. (2021) · Life · doi:10.3390/life11080806 · Cited by 14
“Moreover, pharmacologic inhibition of calpain 10 decreased the activity of glucose transporter GLUT4 in skeletal muscle [39].”
BackgroundTammineni, E. R., Figueroa, L., Manno, C. D., Varma, D., Kraeva, N., Ibarra, C. A., Klip, A., Riazi, S., & Ríos, E. (2023) · eLife · doi:10.7554/elife.78874 · Cited by 16
“This effect, together with the putative cleavage of the regulated glucose transporter GLUT4 ( Otani et al., 2004 ), impair glucose utilization by muscle.”
Cooke, D. W., & Patel, Y. M. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.12.008 · Cited by 14
Dissociation between PGC-1α and GLUT-4 Expression in Skeletal Muscle of Rats Fed a High-Fat Diet
Higashida, K., Higuchi, M., & Terada, S. (2009) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.55.486 · Cited by 14
Skeletal muscle disorders as risk factors for type 2 diabetes
Tammineni, E. R., Manno, C. D., Oza, G., & Figueroa, L. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112466 · Cited by 13
Effects of Yam and Diosgenin on Calpain Systems in Skeletal Muscle of Ovariectomized Rats
Hsu, K.-H., Chang, C.-C., Tsai, H.-D., Tsai, F., & Hsieh, Y. (2008) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(08)60077-7 · Cited by 12
Effect of exercise training on calpain systems in lean and obese Zucker rats
Hsieh, Y., Chang, C.-C., Hsu, K.-H., Tsai, F., Chen, C., & Tsai, H.-D. (2008) · International Journal of Biological Sciences · doi:10.7150/ijbs.4.300 · Cited by 12
“The m-calpain can degrade glucose transporter turnover, which provide evidence for a physiological role of calpains in the adjustment of muscle glucose equilibrium and muscle mass [31].”
Norton, L., Parr, T., Chokkalingam, K., BARDSLEY, R. G., Ye, H. J., Bell, G. I., Pelsers, M. M. A. L., van Loon, L. J. C., & Tsintzas, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1981 · Cited by 9
Self-citationControl of Muscle Metabolism by the Mediator Complex
Amoasii, L., Olson, E. N., & Bassel‐Duby, R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029843 · Cited by 9
“Degradation of GLUT4 by calpain-2 and overexpression of an endogenous calpain inhibitor, calpastatin, has also been shown to increase GLUT4 levels in skeletal muscle (Otani et al. 2004).”
BackgroundTUG is a calpain-10 substrate involved in the translocation of GLUT4 in adipocytes
Pánico, P., Hiriart, M., Ostrosky‐Wegman, P., & Salazar, A. M. (2020) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0253 · Cited by 8
Arsenic impairs GLUT1 trafficking through the inhibition of the calpain system in lymphocytes
Pánico, P., Juárez-Nájera, A., Iturriaga-Goyon, E., Ostrosky‐Wegman, P., & Salazar, A. M. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114700 · Cited by 8
Kishore, R. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000167 · Cited by 5
“Activation of μcalpain has been suggested to be linked to impairment of glucose transporter turnover [23] and ED [9,10,1,24].”
BackgroundPhosphorylation of Serine 157 Protects the Rat Glycine Transporter GlyT2 from Calpain Cleavage
Baliova, M., & Jurský, F. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01529-4 · Cited by 5
Calpain Activity in Leukocytes Is Associated with Diabetes Biochemical Markers
Salazar, A. M., Pánico, P., Burns, A. L., Díaz‐Villaseñor, A., Torres-Arellano, J. M., Juárez-Nájera, A., González-Pimienta, R. E., Alvarez-Sekely, A. M., Zacarías-Castillo, R., & Ostrosky‐Wegman, P. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.11.009 · Cited by 4
Solomon, M. B., Eastridge, J. S., & Paroczay, E. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-79382-5_1 · Cited by 4
“Over expression of CAST, an endogenous calpain inhibitor in transgenic mice resulted in substantially increased muscle tissue (Otani et al., 2004).”
BackgroundChung, H., & Davis, M. E. (2014) · Genes & Genomics · doi:10.1007/s13258-014-0181-1 · Cited by 2
“In addition, Otani et al. (2004) reported that the calpain mediated pathways play an important role in the regulation of a muscle mass.”
BackgroundColagiuri, S., Dickinson, S. P., & Brand-Miller, J. C. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374387-9.00019-2 · Cited by 2
Exploring the Grey Zone between Type 1 and Type 2 Diabetes
Bakhtadze, E. (2009) · Lund University Publications (Lund University) · Cited by 1
Targeting Growth and Atrophy Pathways to Ameliorate Muscle Atrophy and Weakness during Disuse.
Salazar, J. J. (2009) · Deep Blue (University of Michigan)
Czerwinski, E. P. (2007) · OhioLink ETD Center (Ohio Library and Information Network)
Bioengineering of Farm Animals: Meat Quality and Safety
Nollet, L. M. L., & Toldra, F. (2006) · CRC Press eBooks · doi:10.1201/9781420017311-5
The activity and content of calpains in maturing dystrophic muscle membranes
Wang, Q. (2005) · VTechWorks (Virginia Tech)
Kelley, E. F. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Bioengineering of Farm Animals: Meat Quality and Safety
Solomon, M. B., Paroczay, E. W., & Eastridge, J. S. (2006) · Food science and technology · doi:10.1201/9781420017311.ch1
Douillard, A. (2011) · theses.fr (ABES) · doi:10.70675/7b23d860ze248z4f18z92eczba5107bedff7
Balance protéique et phénotype musculaire
Begue, G. (2013) · theses.fr (ABES) · doi:10.70675/19ee01bbz26ecz4fcdz845dzdd59b970d35b · Cited by 1
Mécanismes moléculaires du contrôle de la masse musculaire sous l'action du β2-agoniste formotérol
Joassard, O. (2013) · theses.fr (ABES) · doi:10.70675/251c01fcz1479z415aza11cz70e69f50a189
Cautela, D., Valeria, I., Lombardi, A., Laratta, B., Castaldo, C. M., Balestrieri, M. L., Mocini, E., Migliaccio, S., & Tardito, D. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188057
“In conclusion, GLUT4 abundance is regulated not only at a transcriptional level but also subject to protein turnover, since the transporter undergoes degradation via Calpain 2 action [71].”
Vázquez‐Abuín, X., Gómez-Cibeira, L., García‐Seara, J., de la Fuente-López, P., Minguito‐Carazo, C., Bravo, S. B., Otero-Santiago, M., Gualillo, O., González‐Juanatey, J. R., Lago, F., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202602643r
“Calpain-2 catalytic subunit (CAN2), related to the calpain system involved in cytoskeletal remodeling and the regulation of muscle mass and glucose transporter GLUT4 turnover [77], is also diminished by relaxin-2 in skeletal muscle.”
Metadata
- Authors
- Otani, K., Han, D.-H., Ford, E. L., Garcia-Roves, P. M., Ye, H., Horikawa, Y., Bell, G. I., Holloszy, J. O., & Polonsky, K. S.
- Affiliations
- Washington University in St. Louis (US)
- Howard Hughes Medical Institute (US)
- Gunma University (JP)
- Corresponding author
- Polonsky, Kenneth S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 279
- Issue
- 20
- Pages
- 20915-20920
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1984645442
- Cited by
- 67
- References
- 31
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 3 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 4
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5988 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Funders
- National Institutes of Health (DK31842)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-31842, DK 20595, DK 18966, DK-47486, R01DK047486)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Calpain Protease Function and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Keywords
- calpain, calpastatin, GLUT4, skeletal muscle, muscle mass, insulin resistance, insulin-stimulated glucose transport, Akt, MEF2 transcription factors, m-calpain, glucose metabolism
- MeSH terms
- Animals, Calcium-Binding Proteins, Calpain, Female, Humans, Male, Mice, Transgenic, Monosaccharide Transport Proteins, Muscle Proteins, Organ Size, RNA, Messenger, Sex Characteristics, Muscle, Skeletal, Glucose Transporter Type 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.